A carregar...
Effects of proton pump inhibitors, esomeprazole and vonoprazan, on the disposition of proguanil, a CYP2C19 substrate, in healthy volunteers
AIMS: Vonoprazan, a new class of potassium‐competitive proton pump inhibitors has been found to attenuate the antiplatelet function of clopidogrel in a recent clinical study, despite weak in vitro activity against CYP2C19. To elucidate the mechanism of this interaction, the present study investigate...
Na minha lista:
| Publicado no: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6595331/ https://ncbi.nlm.nih.gov/pubmed/30845361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13914 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|